Format

Send to

Choose Destination
Annu Rev Pharmacol Toxicol. 2016;56:469-87. doi: 10.1146/annurev-pharmtox-010715-103120. Epub 2015 Oct 23.

Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

Author information

1
School of Biological Sciences and Maurice Wilkins Center, University of Auckland, Auckland 1142, New Zealand; email: dl.hay@auckland.ac.nz.
2
Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104; email: augen-pioszak@ouhsc.edu.

Abstract

It is now recognized that G protein-coupled receptors (GPCRs), once considered largely independent functional units, have a far more diverse molecular architecture. Receptor activity-modifying proteins (RAMPs) provide an important example of proteins that interact with GPCRs to modify their function. RAMPs are able to act as pharmacological switches and chaperones, and they can regulate signaling and/or trafficking in a receptor-dependent manner. This review covers recent discoveries in the RAMP field and summarizes the known GPCR partners and functions of RAMPs. We also discuss the first peptide-bound structures of RAMP-GPCR complexes, which give insight into the molecular mechanisms that enable RAMPs to alter the pharmacology and signaling of GPCRs.

KEYWORDS:

CGRP; CRF; GPCR; GPR30; RAMP; VIP; adrenomedullin; amylin; calcium-sensing receptor; heterodimer

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center